Recce Pharmaceuticals: Appoints new CEO

  • Recce Pharmaceuticals (RCE) Board of Directors has unanimously appointed James Graham as the company’s new CEO
  • James has served as Recce’s Executive Director of Marketing and Business Development for the last five years
  • In addition to his new duties as CEO, James will continue to serve as a Director on the Board
  • His appointment takes effect on August 28, and comes with an annual salary of $300,000
  • James will oversee the company as it approaches a number of critical milestones, including a clinical trial and COVID-19 studies
  • Recce Pharmaceuticals closed 0.37 per cent in the red for $1.36 each
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Currenxie Launches Cross-Border Payments Account for SMEs in the UK

New service aims to streamline international transactions for small businesses.Highlights: Currenxie launches a new account for cross-border payments...

Coinbase Expands Services by Adding Stock Trading for US Customers

New feature allows users to trade stocks alongside cryptocurrencies.Highlights: Coinbase introduces stock trading for US customers.Users can now...

Commonwealth Bank Unveils $90M Plan for AI-Ready Workforce

Investment targets workforce development in the age of artificial intelligence.Highlights: Commonwealth Bank invests $90 million in AI workforce...

Royal Bank of Canada Strengthens AI Capabilities with New Dedicated Team

The initiative aims to enhance customer experience and drive innovation.Highlights: Royal Bank of Canada establishes a dedicated AI...